Clinical Trial Update: AURORAX-0093A: Glycosaminoglycan Profiling for Prognostication of Muscle-invasive Bladder Cancer - a Pilot Study

View source ↗

Summary

This clinical trial update reports on a pilot study evaluating glycosaminoglycan profiling as a prognostic tool for muscle-invasive bladder cancer. The study ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle-invasive Bladder Cancer

Snippet

Sponsor: Elypta | Conditions: Muscle-Invasive Bladder Carcinoma | Status: COMPLETED